Richard L Page
Affiliation: University of Wisconsin
- Cardiac arrest at exercise facilities: implications for placement of automated external defibrillatorsRichard L Page
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin University of Washington School of Medicine, Seattle, Washington Electronic address
J Am Coll Cardiol 62:2102-9. 2013..This study sought to characterize the relative frequency, care, and survival of sudden cardiac arrest in traditional indoor exercise facilities, alternative indoor exercise sites, and other indoor sites...
- The AED in resuscitation: it's not just about the shockRichard L Page
University of Wisconsin School of Medicine and Public Health, Suite 5000, 1685 Highland Ave, Madison, WI 53705 2281, USA
Trans Am Clin Climatol Assoc 122:347-55. 2011..Prospective research, as undertaken by the Resuscitation Outcomes Consortium, will be the key to future refinements of the guidelines and enhanced survival with use of the AED in sudden cardiac arrest...
- Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial)Richard L Page
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
Am J Cardiol 107:1019-22. 2011..001). In conclusion, dronedarone demonstrated both rhythm- and rate-controlling properties in ATHENA. These effects are likely to contribute to the reduction of important clinical outcomes observed in this trial...
- Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillationEdward L C Pritchett
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
J Clin Pharmacol 42:388-94. 2002..It was concluded that in patients with a history of atrial fibrillation or flutter, azimilide was associated with statistically significant increases in RR, QT, QTc(Bazett), and QTc(Fridericia) when patients were in sinus rhythm...
- Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmiasRichard L Page
Division of Cardiology, University of Washington School of Medicine, Seattle, Washington 98195 6422, USA
J Cardiovasc Electrophysiol 19:172-7. 2008..This study was designed to confirm efficacy of 125 mg daily azimilide...
- Public access defibrillationRobert W Rho
Department of Medicine, University of Washington, Seattle, WA 98195 6422, USA
Heart Fail Clin 7:269-76, ix. 2011..This article discusses the technologic features of the modern AED and the current data available on the use of AEDs in public settings...
- Approach to the diagnosis and initial management of the stable adult patient with a wide complex tachycardiaZachary D Goldberger
Department of Internal Medicine, University of Washington Medical Center, VA Puget Sound Health Care System, Seattle, Washington, USA
Am J Cardiol 101:1456-66. 2008....
- The automated external defibrillatorRobert W Rho
University of Washington School of Medicine, Seattle, Washington 98195 6422, USA
J Cardiovasc Electrophysiol 18:896-9. 2007..We encourage widespread implementation of PAD programs and enhanced public awareness about basic life support, with the expectation that such efforts will enhance survival of out of hospital cardiac arrest...
- Asymptomatic atrial fibrillationRobert W Rho
Department of Medicine Division of Cardiology, University of Washington School of Medicine, Seattle, WA, 98195 6422, USA
Prog Cardiovasc Dis 48:79-87. 2005..This manuscript provides an overview of the clinical entity of asymptomatic AF including the epidemiology, clinical significance, and the implications it has on the daily management of patients suffering from AF...
- Medical management of atrial fibrillation: future directionsRichard L Page
Department of Internal Medicine Cardiology Division, University of Washington School of Medicine, Seattle, Washington 98195 6422, USA
Heart Rhythm 4:S91-4. 2007..It is hoped that efforts to develop new drugs, including those with preferential effects on the atrium, will provide therapy with greater efficacy and safety...
- Wenckebach periodicity at rest that normalizes with tachycardia in a family with a NKX2.5 mutationWarren Guntheroth
Division of Cardiology, Department of Pediatrics, University of Washington, Seattle, Washington, USA
Am J Cardiol 110:1646-50. 2012..5. In addition, the physiology of WP is reviewed in these subjects and in highly conditioned athletes. In conclusion, the investigators report familial stable WP and ventricular noncompaction caused by a mutation in NKX2.5...
- Diabetes mellitus, glycemic control, and risk of atrial fibrillationSascha Dublin
Group Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101 1448, USA
J Gen Intern Med 25:853-8. 2010..Diabetes may be an independent risk factor for atrial fibrillation. However, results from prior studies are in conflict, and no study has examined diabetes duration or glycemic control...
- Pharmacological therapy of atrial fibrillationKristen K Patton
University of Washington Medical Center, Division of Cardiology, 1959 NE Pacific Street, Box 356422, Seattle, WA 98122, USA
Expert Opin Investig Drugs 16:169-79. 2007..This review concentrates on both the classical and novel pharmacological therapies aimed at maintaining sinus rhythm...
- Biphasic versus monophasic shock waveform for conversion of atrial fibrillationRobert W Rho
The University of Washington School of Medicine, Seattle, WA 98195 6422, USA
Card Electrophysiol Rev 7:290-1. 2003..We recommend starting with biphasic energy of 100 J for atrial fibrillation of less than 48 hours duration, but using higher energies (150 J, 200 J or greater) when AF has been present for longer periods...
- Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trialDariush Mozaffarian
Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
JAMA 308:2001-11. 2012..A few small trials have evaluated whether long-chain n-3-polyunsaturated fatty acids (PUFAs) reduce postoperative AF, with mixed results...
- Pharmacological therapy for atrial fibrillation: current options and new agentsMohan N Viswanathan
University of Washington, Division of Cardiology Cardiac Electrophysiology, Seattle, WA 98195 6422, USA
Expert Opin Investig Drugs 18:417-31. 2009..This review focuses on the current and potential future pharmacological agents directed at rhythm control and maintenance of sinus rhythm...
- Seasonal variation of mortality in the Antiarrhythmics Versus Implantable Defibrillators (AVID) study registryRichard L Page
Department of Internal Medicine, Cardiology Division, University of Washington School of Medicine, Seattle, 98195, USA
Heart Rhythm 1:435-40. 2004..We postulated that the pattern of death would be nonrandom with respect to temporal variables...
- Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: efficacy and dose-responseRichard L Page
Department of Medicine, Cardiovascular Division, University of Texas Southwestern Medical Center, Parkland Memorial Hospital, Dallas, Tex 75390 9047, USA
Am Heart J 143:643-9. 2002..Its effect on paroxysmal supraventricular tachycardia (PSVT) has not been reported...